Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
January 28, 2020
Patent Application Number
15541594
Date Filed
January 8, 2016
Patent Citations Received
Patent Primary Examiner
Patent abstract
Bispecific antibodies directed to CD3 and CD20 and uses of such bispecific antibodies, in particular use thereof in the treatment of diseases in which specific targeting and T cell-mediated killing of cells that express CD20 is desired.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
